Pictured above: The REDCapCon in Boston drew 377 registrants from 263 institutions spanning 42 states and 22 countries on six continents.
REDCap administrators from around the world recently attended the 14th edition of REDCapCon in Boston, hosted this year by Harvard Catalyst, Harvard University’s center for clinical and translational science.
Participating from Vanderbilt University Medical Center were 15 members of the team that brought REDCap to the world. REDcap is a research-oriented web-based software application launched at VUMC in 2004 by Paul Harris, PhD, professor of Biomedical Informatics and director of the Office of Research Informatics, and now maintained for users around the world by Harris’ team at the Vanderbilt Institute for Clinical and Translational Research, where Rob Taylor serves as manager of application development.
At last count, REDCap had users at 6,167 institutions in 147 countries. The Boston conference drew 377 registrants from 263 institutions spanning 42 states and 22 countries on six continents.
Among the program highlights was an account of how a team at Oxford University in England used REDCap to provide comprehensive support for AstraZeneca COVID vaccine trials.